REPLIGEN CORP
Public company- Headquarters
- WALTHAM, Massachusetts
- Industry
- Biotechnology
- Ticker
- RGEN
- CIK
- 0000730272
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
0 appointments, 1 departure
Last event
Sep 15, 2026
Executive departureBoard of Directors departs: Karen A. Dawes
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Board of DirectorsKaren A. Dawes | Sep 15, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Eloxx Pharmaceuticals, Inc.
director appointed: Geno J. Germano
- Voyager Therapeutics, Inc.
president appointed: Robin Swartz
- TScan Therapeutics, Inc.
Director departs: Garry Nicholson
- Moderna, Inc.
COO appointed: Juan Andres
- Executive departure
Board of Directors departs: Karen A. Dawes
Karen A. Dawes, Board of Directors of REPLIGEN CORP, retires the role, effective September 30, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 15, 2026Role: Board of Directors
Only one public record so far. We add events as soon as a new filing lands; watch REPLIGEN CORP to get them in your digest.
Last verified Nov 8, 2026